These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15772918)

  • 1. Hemodialysis access graft failure: time to revisit an unmet clinical need?
    Rotmans JI; Pasterkamp G; Verhagen HJ; Pattynama PM; Blankestijn PJ; Stroes ES
    J Nephrol; 2005; 18(1):9-20. PubMed ID: 15772918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving access patency: pre-end-stage renal disease strategies.
    Schwab SJ
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S124-9. PubMed ID: 11443759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated expression of beta-adrenergic receptor kinase C-terminus reduces intimal hyperplasia and luminal stenosis of arteriovenous polytetrafluoroethylene grafts in pigs.
    Luo Z; Akita GY; Date T; Treleaven C; Vincent KA; Woodcock D; Cheng SH; Gregory RJ; Jiang C
    Circulation; 2005 Apr; 111(13):1679-84. PubMed ID: 15781730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus-eluting stents to abolish intimal hyperplasia and improve flow in porcine arteriovenous grafts: a 4-week follow-up study.
    Rotmans JI; Pattynama PM; Verhagen HJ; Hino I; Velema E; Pasterkamp G; Stroes ES
    Circulation; 2005 Mar; 111(12):1537-42. PubMed ID: 15781738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary arteriovenous fistulas: converting prosthetic AV grafts to autogenous dialysis access.
    Slayden GC; Spergel L; Jennings WC
    Semin Dial; 2008; 21(5):474-82. PubMed ID: 18627564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endovascular dialysis interventions in the era of DOQI.
    Greenberg JI; Suliman A; Angle N
    Ann Vasc Surg; 2008 Sep; 22(5):657-62. PubMed ID: 18619775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patency rate and complications of vascular access grafts for hemodialysis in lower extremities.
    Salimi J
    Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):929-32. PubMed ID: 18974578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some old drugs improve late primary patency rate of native arteriovenous fistulas in hemodialysis patients.
    Righetti M; Ferrario G; Serbelloni P; Milani S; Tommasi A
    Ann Vasc Surg; 2009; 23(4):491-7. PubMed ID: 18973987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anterior chest wall arteriovenous grafts: an underutilized form of hemodialysis access.
    Niyyar VD
    Semin Dial; 2008; 21(6):578-80. PubMed ID: 19000127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access flow after angioplasty predicts subsequent arteriovenous graft survival.
    Murray BM; Herman A; Mepani B; Rajczak S
    J Vasc Interv Radiol; 2006 Feb; 17(2 Pt 1):303-8. PubMed ID: 16517776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular brachytherapy for hemodialysis vascular access dysfunction: exploring an unmet clinical need.
    Roy-Chaudhury P; Duncan H; Barrett W; Elson H; Narayana A; Foley J; Misra S; Lynch PM; Zuckerman D
    J Invasive Cardiol; 2003 Jan; 15 Suppl A():25A-30A. PubMed ID: 12668839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of autologous antebrachial arteriovenous fistula for vascular access in hemodialysis].
    Szeberin Z; Bíró G; Sótonyi P; Soós P; Százados M; Arkossy O; Berta K; Acsády G
    Magy Seb; 2006 Dec; 59(6):421-8. PubMed ID: 17432082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter evaluation of the bovine mesenteric vein bioprostheses for hemodialysis access in patients with an earlier failed prosthetic graft.
    Katzman HE; Glickman MH; Schild AF; Fujitani RM; Lawson JH
    J Am Coll Surg; 2005 Aug; 201(2):223-30. PubMed ID: 16038820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical versus percutaneous care of arteriovenous access.
    Gelbfish GA
    Semin Vasc Surg; 2007 Sep; 20(3):167-74. PubMed ID: 17884618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodialysis vascular access dysfunction: molecular mechanisms and treatment.
    Mima A
    Ther Apher Dial; 2012 Aug; 16(4):321-7. PubMed ID: 22817119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The advantages of end-to-side arteriovenous anastomosis over the other two types of arteriovenous anastomosis in dialysis patients.
    Galić G; Kvesić A; Tomić M; Rebac Z; Brekalo Z; Martinović V; Vuckov S
    Coll Antropol; 2008 Mar; 32(1):109-14. PubMed ID: 18494195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin converting enzyme inhibitors maintain polytetrafluroethylene graft patency.
    Sajgure A; Choudhury A; Ahmed Z; Choudhury D
    Nephrol Dial Transplant; 2007 May; 22(5):1390-8. PubMed ID: 17267534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of the fish oil inhibition of stenosis in hemodialysis grafts (FISH) study.
    Lok CE; Allon M; Donnelly S; Dorval M; Hemmelgarn B; Moist L; Oliver MJ; Tonelli M; Stanley K
    Clin Trials; 2007; 4(4):357-67. PubMed ID: 17848497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular access outcomes and medication use: a USRDS study.
    Yevzlin AS; Conley EL; Sanchez RJ; Young HN; Becker BN
    Semin Dial; 2006; 19(6):535-9. PubMed ID: 17150056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renal replacement therapy by hemodialysis: an overview].
    Jacobs C
    Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.